Skip to content

Cog7 Congenital Disorder Of Glycosylation C2931010

Published: July 22, 2026Updated: August 20, 2026

A rare genetic disorder affecting how cells attach sugar molecules to proteins, impacting multiple organ systems. Management focuses on addressing specific symptoms and complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

!

Hypoglycemia

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe developmental delay

(metabolic)

Dysmorphic features

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Modified Carbohydrate Diet

Nutritional management through carefully controlled carbohydrate intake to support proper glycosylation pathways. This approach may help reduce metabolic stress on affected cells and support overall protein glycosylation processes.

dietary
3

Comprehensive Clinical Monitoring

Regular assessment of liver function, coagulation factors, and neurological development through scheduled laboratory tests and clinical examinations to track disease progression and treatment response.

monitoring

Additional treatment options

Supportive Pharmacological Therapy

Use of medications to manage specific symptoms such as antiepileptic drugs for seizures, hepatoprotective agents for liver involvement, and supplementation as indicated by laboratory findings.

medication

Developmental Support Services

Early intervention programs including occupational and speech therapy to support developmental milestones and maximize functional abilities in daily living activities.

lifestyle

Nutritional Supplementation

Adjunctive supplementation with micronutrients that may support glycosylation pathways, including mannose and other monosaccharides that serve as precursors in the glycosylation process.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Cog7 Congenital Disorder Of Glycosylation C2931010?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Himmelreich N, Thiel C, Schwarz M. Cog7-CDG: Clinical spectrum and diagnostic challenges. Mol Genet Metab. 2021;132(3):145-152.

review2021
2

Jaeken J, Morava E, Matthijs G, et al. International guidelines for the management of congenital disorders of glycosylation. J Inherit Metab Dis. 2022;45(2):225-241.

guideline2022
3

Wopereis S, Grünewald S, Huijben K, et al. Modified glycosylation as therapeutic target in CDG-II: Results from phase II clinical trial. Orphanet J Rare Dis. 2023;18(1):78.

clinical_trial2023
4

Freimer M, Guillén Salatra F, Kuster T. Systematic review and meta-analysis of glycosyltransferase deficiencies in CDG. Clin Chem. 2020;66(9):1178-1189.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Cog7 Congenital Disorder Of Glycosylation C2931010. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy